Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy

Jason V Baker; Jacqueline Neuhaus; Daniel Duprez; David A Cooper; Jennifer F Hoy; Lewis H Kuller; Fiona Lampe; Angelike P Liappis; Nina Friis-Moller; James Otvos; Nick I Paton; Russell Tracy; James D Neaton

doi:10.1097/QAD.0b013e32834be088

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy

Jason V Baker, Jacqueline Neuhaus, Daniel Duprez, David A Cooper, Jennifer F Hoy, Lewis H Kuller, Fiona Lampe, Angelike P Liappis, Nina Friis-Moller, James Otvos, Nick I Paton, Russell Tracy, James D Neaton

Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

49 Citations (Scopus)

Abstract

In a subgroup of participants not taking ART at study entry who were randomized in the Strategies for Management of Antiretroviral Therapy (SMART) trial to immediately initiate ART ( viral suppression group ) or to defer it ( drug conservation group ), lipoprotein particle concentrations and ApoA1 and ApoB levels were measured at baseline and at 2 and 6 months following randomization.

Original language	English
Pages (from-to)	2133 - 2142
Number of pages	10
Journal	AIDS
Volume	25
Issue number	17
DOIs	https://doi.org/10.1097/QAD.0b013e32834be088
Publication status	Published - 2011

Access to Document

10.1097/QAD.0b013e32834be088

Cite this

Baker, J. V., Neuhaus, J., Duprez, D., Cooper, D. A., Hoy, J. F., Kuller, L. H., Lampe, F., Liappis, A. P., Friis-Moller, N., Otvos, J., Paton, N. I., Tracy, R., & Neaton, J. D. (2011). Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy. AIDS, 25(17), 2133 - 2142. https://doi.org/10.1097/QAD.0b013e32834be088

@article{d361f7703baf4aa7a19ce73dd920e876,

title = "Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy",

abstract = "In a subgroup of participants not taking ART at study entry who were randomized in the Strategies for Management of Antiretroviral Therapy (SMART) trial to immediately initiate ART ( viral suppression group ) or to defer it ( drug conservation group ), lipoprotein particle concentrations and ApoA1 and ApoB levels were measured at baseline and at 2 and 6 months following randomization.",

author = "Baker, \{Jason V\} and Jacqueline Neuhaus and Daniel Duprez and Cooper, \{David A\} and Hoy, \{Jennifer F\} and Kuller, \{Lewis H\} and Fiona Lampe and Liappis, \{Angelike P\} and Nina Friis-Moller and James Otvos and Paton, \{Nick I\} and Russell Tracy and Neaton, \{James D\}",

year = "2011",

doi = "10.1097/QAD.0b013e32834be088",

language = "English",

volume = "25",

pages = "2133 -- 2142",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams \& Wilkins",

number = "17",

}

Baker, JV, Neuhaus, J, Duprez, D, Cooper, DA, Hoy, JF, Kuller, LH, Lampe, F, Liappis, AP, Friis-Moller, N, Otvos, J, Paton, NI, Tracy, R & Neaton, JD 2011, 'Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy', AIDS, vol. 25, no. 17, pp. 2133 - 2142. https://doi.org/10.1097/QAD.0b013e32834be088

TY - JOUR

T1 - Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy

AU - Baker, Jason V

AU - Neuhaus, Jacqueline

AU - Duprez, Daniel

AU - Cooper, David A

AU - Hoy, Jennifer F

AU - Kuller, Lewis H

AU - Lampe, Fiona

AU - Liappis, Angelike P

AU - Friis-Moller, Nina

AU - Otvos, James

AU - Paton, Nick I

AU - Tracy, Russell

AU - Neaton, James D

PY - 2011

Y1 - 2011

N2 - In a subgroup of participants not taking ART at study entry who were randomized in the Strategies for Management of Antiretroviral Therapy (SMART) trial to immediately initiate ART ( viral suppression group ) or to defer it ( drug conservation group ), lipoprotein particle concentrations and ApoA1 and ApoB levels were measured at baseline and at 2 and 6 months following randomization.

AB - In a subgroup of participants not taking ART at study entry who were randomized in the Strategies for Management of Antiretroviral Therapy (SMART) trial to immediately initiate ART ( viral suppression group ) or to defer it ( drug conservation group ), lipoprotein particle concentrations and ApoA1 and ApoB levels were measured at baseline and at 2 and 6 months following randomization.

UR - https://www.scopus.com/pages/publications/80055054267

U2 - 10.1097/QAD.0b013e32834be088

DO - 10.1097/QAD.0b013e32834be088

M3 - Article

SN - 0269-9370

VL - 25

SP - 2133

EP - 2142

JO - AIDS

JF - AIDS

IS - 17

ER -

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy

Abstract

Access to Document

Other files and links

Cite this